Kirkland Advises GTCR on Strategic Investment in Resonetics by Carlyle
Kirkland & Ellis advised GTCR, a leading private equity firm, and its portfolio company, Resonetics, on the sale of a minority equity stake in Resonetics to funds affiliated with global investment firm Carlyle (NASDAQ: CG), valuing Resonetics at approximately $2.25 billion. Carlyle will join GTCR as a meaningful shareholder in Resonetics as a result of the transaction.
The Kirkland team was led by corporate partners Christopher Thomas, Michael Weed and Sanford Perl and associate Daniella Vespoli.
